Articles
Biosimilars… can the truth set you free?

Biosimilars… can the truth set you free?

Biosimilars – a disruptive technology or an unmissable opportunity? Duncan Emerton and Martyn Smith shed light on the topic and dispel some industry myths. The truth, it is said, is hard to take. No more so in pharmaceutical industry, it seems. The emergence of a new…

Articles
A history of: Contract Research Organisations (CROs)

A history of: Contract Research Organisations (CROs)

In the latest part of his series on the history of pharma, Robin Walsh looks at the history of the Contract Research industry. Whilst most of those working in the pharmaceutical industry have felt the pressures of rising costs and thinning pipelines over the last twenty years...

Articles
“Accelerated word of mouth” – is this the new pharma model?

“Accelerated word of mouth” – is this the new pharma model?

Pete West looks at how digital communications has accelerated ‘word of mouth’ in the 21st century, but is it to pharma’s benefit? Listen, my children, and you shall hear Of the midnight ride of Paul Revere. You may recognize the opening lines of this verse by…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more